| Serial Number | 88056116 |
| Word Mark | VALENSCION |
| Filing Date | Friday, July 27, 2018 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, October 10, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 9, 2019 |
| Goods and Services | Pharmaceuticals for use in the treatment of viral infection, bacterial infection, asthma, allergies, cancer, transplant rejection, inflammatory diseases and disorders, immune diseases and disorders, hereditary diseases and disorders, namely, metabolic, endocrine, neurologic and cardiovascular diseases or disorders, and auto immune diseases and disorders; pharmaceuticals for use in the treatment of T-cell and B-cell leukemias and lymphomas; medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, biologically active antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; medical therapeutic preparations, namely, small molecule chemicals aimed at inhibiting cellular proteins |
| Goods and Services | Medical research; scientific research; biological research; chemical research; pharmaceutical research services; pharmaceutical research and development; product research and development; medical and scientific research in the area of oligonucleotides or chemical products; medical and scientific research in the area of the structure-based drug design; biological and chemical research in the field of immunology, virology, oncology and hereditary diseases; medical and scientific research in the area of small molecule chemicals aimed at inhibiting cellular proteins for use as therapeutic agents; pharmaceutical research and development in the field of infectious diseases and disorders, cancer, viral diseases and disorders, inflammatory diseases and disorders, immunological diseases and disorders, autoimmune diseases and disorders, hereditary diseases and disorders, and cardiovascular diseases and disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 2, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 2, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Idera Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Exton, PA 19341 |
| Party Name | Idera Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Exton, PA 19341 |
| Event Date | Event Description |
| Tuesday, October 11, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, October 10, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Thursday, February 24, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, February 23, 2022 | SOU EXTENSION 5 GRANTED |
| Wednesday, February 16, 2022 | SOU EXTENSION 5 FILED |
| Wednesday, February 23, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, February 16, 2022 | TEAS EXTENSION RECEIVED |
| Wednesday, September 1, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 30, 2021 | SOU EXTENSION 4 GRANTED |
| Monday, August 30, 2021 | SOU EXTENSION 4 FILED |
| Monday, August 30, 2021 | TEAS EXTENSION RECEIVED |
| Friday, March 5, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, March 3, 2021 | SOU EXTENSION 3 GRANTED |
| Wednesday, March 3, 2021 | SOU EXTENSION 3 FILED |
| Wednesday, March 3, 2021 | TEAS EXTENSION RECEIVED |
| Wednesday, February 10, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, February 10, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, February 10, 2021 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Wednesday, February 10, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, February 10, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, February 10, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Saturday, September 5, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, September 3, 2020 | SOU EXTENSION 2 GRANTED |
| Thursday, September 3, 2020 | SOU EXTENSION 2 FILED |
| Thursday, September 3, 2020 | TEAS EXTENSION RECEIVED |
| Thursday, March 5, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, March 3, 2020 | SOU EXTENSION 1 GRANTED |
| Tuesday, March 3, 2020 | SOU EXTENSION 1 FILED |
| Tuesday, March 3, 2020 | TEAS EXTENSION RECEIVED |
| Tuesday, September 3, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 9, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 9, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 19, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 4, 2019 | ASSIGNED TO LIE |
| Wednesday, May 22, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, May 14, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 14, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 14, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 20, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, November 20, 2018 | NON-FINAL ACTION E-MAILED |
| Tuesday, November 20, 2018 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 14, 2018 | ASSIGNED TO EXAMINER |
| Thursday, August 2, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, July 31, 2018 | NEW APPLICATION ENTERED IN TRAM |